DocGo Future Growth

Future criteria checks 0/6

DocGo's revenue and earnings are forecast to decline at 21.8% and 50.7% per annum respectively. EPS is expected to decline by 55.4% per annum. Return on equity is forecast to be 8.2% in 3 years.

Key information

-50.7%

Earnings growth rate

-55.4%

EPS growth rate

Healthcare earnings growth20.8%
Revenue growth rate-21.8%
Future return on equity8.2%
Analyst coverage

Good

Last updated08 Nov 2024

Recent future growth updates

Recent updates

DocGo Inc. (NASDAQ:DCGO) Doing What It Can To Lift Shares

Aug 05
DocGo Inc. (NASDAQ:DCGO) Doing What It Can To Lift Shares

At US$3.40, Is DocGo Inc. (NASDAQ:DCGO) Worth Looking At Closely?

Jul 17
At US$3.40, Is DocGo Inc. (NASDAQ:DCGO) Worth Looking At Closely?

These 4 Measures Indicate That DocGo (NASDAQ:DCGO) Is Using Debt Safely

Jun 11
These 4 Measures Indicate That DocGo (NASDAQ:DCGO) Is Using Debt Safely

DocGo: Upside Remains Attractive After Share Price Decline

Mar 20

Does DocGo (NASDAQ:DCGO) Have A Healthy Balance Sheet?

Feb 13
Does DocGo (NASDAQ:DCGO) Have A Healthy Balance Sheet?

DocGo: Good Performance, Trust Issues

Feb 05

Why DocGo Inc. (NASDAQ:DCGO) Could Be Worth Watching

Jan 25
Why DocGo Inc. (NASDAQ:DCGO) Could Be Worth Watching

Fewer Investors Than Expected Jumping On DocGo Inc. (NASDAQ:DCGO)

Jan 04
Fewer Investors Than Expected Jumping On DocGo Inc. (NASDAQ:DCGO)

New Forecasts: Here's What Analysts Think The Future Holds For DocGo Inc. (NASDAQ:DCGO)

Nov 08
New Forecasts: Here's What Analysts Think The Future Holds For DocGo Inc. (NASDAQ:DCGO)

Is Now The Time To Look At Buying DocGo Inc. (NASDAQ:DCGO)?

Jun 07
Is Now The Time To Look At Buying DocGo Inc. (NASDAQ:DCGO)?

DocGo Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

May 10
DocGo Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

DocGo Inc.'s (NASDAQ:DCGO) Price In Tune With Earnings

Apr 07
DocGo Inc.'s (NASDAQ:DCGO) Price In Tune With Earnings

DocGo's UK subsidiary Ambulnz Community Partners secures three new contracts

Sep 20

DocGo: 'Last Mile' Care More Palatable To The Public Than Telemedicine

Aug 31

Earnings and Revenue Growth Forecasts

NasdaqCM:DCGO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202645512N/AN/A5
12/31/20254198N/AN/A7
12/31/202462527N/AN/A7
9/30/2024695314352N/A
6/30/202474330-34-25N/A
3/31/202470322-60-52N/A
12/31/20236247-74-64N/A
9/30/20235347-75-67N/A
6/30/20234526-23-14N/A
3/31/202343620-20-13N/A
12/31/2022441352329N/A
9/30/2022453502329N/A
6/30/2022435502429N/A
3/31/2022387361118N/A
12/31/202131924-9-2N/A
9/30/2021229-4-24N/A
6/30/2021170-10-15-9N/A
3/31/2021130-10-13-7N/A
12/31/202094-14-17-11N/A
12/31/201948-20-18-14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DCGO's earnings are forecast to decline over the next 3 years (-50.7% per year).

Earnings vs Market: DCGO's earnings are forecast to decline over the next 3 years (-50.7% per year).

High Growth Earnings: DCGO's earnings are forecast to decline over the next 3 years.

Revenue vs Market: DCGO's revenue is expected to decline over the next 3 years (-21.8% per year).

High Growth Revenue: DCGO's revenue is forecast to decline over the next 3 years (-21.8% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DCGO's Return on Equity is forecast to be low in 3 years time (8.2%).


Discover growth companies